Prosecution Insights
Last updated: November 04, 2026

Molecular Transfer Inc.

Technology area: Biotechnology & Pharmaceuticals

2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready

Analysis

Molecular Transfer Inc. has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This action is assigned to 1 distinct examiner, RAGHU, GANAPATHIRAM, who is also the busiest examiner for the company. The portfolio is currently limited to 1 distinct art unit, which implies a specific technical focus within the broader biotechnology field. With 1 pending office action, the company is navigating the examination process for its latest innovation.

Because RAGHU, GANAPATHIRAM is responsible for the 1 busiest examiner pending action, the prosecution effort is entirely concentrated. This lack of diversification means the outcome of the 1 pending office action relies on the specific feedback of a single examiner. However, the presence of only 1 distinct art unit means that the prosecution team only needs to adapt to the procedural nuances of one departmental group. This allows for a highly targeted approach to resolving the 1 pending office action while ensuring technical consistency with the standards of the assigned art unit.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

2
Total Pending OAs
2
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
1
Medium (50%)
0
Easy (0%)
1
Unknown (50%)

Rejection Statute Mix

BucketCases
Double-patenting + other1 (50%)
No statute on record1 (50%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

2
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

20 h
Manual time on pending OAs
4 h
Time saved (low, 20%)
7 h
Time saved (mid, 35%)
0.2 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
RAGHU, GANAPATHIRAM 1 73.8% +26.3%
KELLY, ROBERT M 1 74.1% +24.1%

Interview Candidates (2)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18771323 AGENTS FOR IMPROVED DELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS RAGHU, GANAPATHIRAM —
18747146 POLYCATIONIC METHYL PHOSPHOLIPIDS FOR IMPROVED DELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS KELLY, ROBERT M —

Top Art Units

Art UnitApps
1652 1
1638 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18771323 AGENTS FOR IMPROVED DELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS RAGHU, GANAPATHIRAM 1652 §102§103DPOther Non-Final OA — Pending Jul 12, 2024
18747146 POLYCATIONIC METHYL PHOSPHOLIPIDS FOR IMPROVED DELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS KELLY, ROBERT M 1638 Other Non-Final OA — Pending Jun 18, 2024

Managing Molecular Transfer Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Molecular Transfer Inc. have?

Molecular Transfer Inc. has 2 pending office actions as of November 2026, spread across 2 art units and 2 examiners.

Which USPTO examiner handles the most Molecular Transfer Inc. applications?

Ganapathiram Raghu has the most, with 1 of Molecular Transfer Inc.'s pending office actions.

What technology area are Molecular Transfer Inc.'s patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month